EDITORIAL |
*
Fibrillary glomerulonephritis / immunotactoid nephropathy
|
4-9 |
*
Prehypertension: how to evaluate the clinical and prognostic significance?
|
10-15 |
*
Is tonsillectomy indicated in chronic glomeprulonephritis?
|
16-18 |
HOTLINE TOPIC |
N.A. Moukhin, I.I. Nadelyaeva
Controlled clinical trials in nephrology
|
19-22 |
STATE-OF-ART |
L.V. Kozlovskaya, Yu.S. Milovanov, L.Yu. Milovanova, I.A. Dobrosmislov
Difficulties in renal anemia treatment. Role of prolonged erythropoietin receptor activator
|
23-27 |
ORIGINAL PAPERS |
M.M. Volkov, A.V. Smirnov, O.A. Degtereva, E.V. Kirillova, L.A. Gordeeva
Calcinosis of abdominal aorta in chronic kidney disease patients, not receiving renal replacement therapy
|
28-31 |
G.P. Arutiunov, A.G. Arutiunov, D.D. Pashkevich, A.V. Grishina, N.O. Balanina, N.Yu Voevodina, N.R. Kaminina
Glomerulary filtration rate in chronic heart failure patients. (Program for estimation of bacterial infection influence on kidney function in patients with chronic kidney failure)
|
32-39 |
N.A. Moukhin, E.N. Semenkova, O.G. Krivosheev , P.I. Novikov
Use of rituximab in severe ANCA-associated vasculitidis
|
40-45 |
B.Z. Sirotin, K.V. Zhmerenetskii, E.V. Zhmerenetskaya
State of microcirculation and microalbuminuria in patients with arterial hypertension
|
46-49 |
A. Shnaider
Comparison of distribution of erythropoietin medications isoforms with two-dimensional gel-electrophoresis
|
50-53 |
HISTORY OF NEPHROLOGY |
E.M. Tareev, N.A. Ratner
Renal oedema pathogenesis
|
54-59 |
EPIDEMIOLOGY AND PREVENTION |
I.A. Bondar, V.V. Klimontov
Early markers of diabetic nephropathy
|
60-65 |
E.A. Saginova, M.G. Gallyamov, M.M. Severova
Update on renal affection in obesity
|
66-71 |
EVERYDAY CLINICAL PRACTICE NOTES |
V.V. Fomin, S.S. Girina
Perspectives on long-acting dihydropiridine calcium antagonists in treatment and prophylaxis of chronic kidney disease
|
72-76 |
NEPHROLOGY EPONIMS |
*
Von Willebrand Factor
|
77-79 |
DATE |
*
100 year anniversary of Kakovsky-Addis test
|
80-80 |